Newsfeeds - Spark Newswire

1 minute read

News
SEC

Biophytis Changes Ratio Under ADR Program To One ADS Representing 100 Shares From One ADS Representing 10 Shares Effective March 30

Today, 10:44 PM

Biophytis SA ((NasdaqCM:BPTS, PARIS:ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes

BPTS

2 minute read

Why Cassava Sciences Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

By Lisa Levin

Today, 10:44 PM

Gainers

ASAN

2 minute read

Why Heritage Insurance Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

By Lisa Levin

Today, 10:44 PM

Gainers ObsEva SA (NASDAQ: OBSV) rose 93.1% to $0.2047 in pre-market trading after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.

1 minute read

News

Biophytis Cuts Deal With Intsel Chimos To Operate Sarconeos (BIO101) in France for Treatment of COVID-19

By Benzinga Newsdesk

Today, 10:44 PM

Biophytis SA (NASDAQ:BPTS) (the "Company" or "Biophytis"), a biotechnology company focused on the development of drugs to slow the degenerative processes associated with aging, including severe

BPTS

1 minute read

Biophytis Seeks Early Access Authorization For Its COVID-19 Treatment In France

By Vandana Singh

Today, 10:44 PM

Biophytis SA (NASDAQ:BPTS) has begun the early access application process in France for Sarconeos (BIO101) for the treatment of severe COVID-19.…

BPTS

1 minute read

Biophytis Initiates Early Access Authorization from French National Authority for Health (HAS) for Treatment of Severe COVID-19 with Sarconeos

By Benzinga Newsdesk

Today, 10:44 PM

Biophytis SA ((NasdaqCM: BPTS, PARIS:ALBPS) (the "Company" or "Biophytis"), a biotechnology company focused on the development of drugs to slow the degenerative processes associated with aging,

BPTS

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 10:44 PM

Gainers Catalent (NYSE:CTLT) shares increased by 27.6% to $71.5 during Monday’s pre-market session. The market value of their…

ADIL

1 minute read

HC Wainwright & Co. Reiterates Buy on Biophytis, Maintains $15 Price Target

By Benzinga Newsdesk

Today, 10:44 PM

HC Wainwright & Co. analyst Joseph Pantginis reiterates Biophytis (NASDAQ:BPTS) with a Buy and maintains $15 price target.

BPTS

5 minute read

Earnings

Earnings Scheduled For January 31, 2023

By Benzinga Insights

Today, 10:44 PM

Companies Reporting Before The Bell • Biophytis (NASDAQ:BPTS) is projected to report earnings for its first quarter.

ALGM

1 minute read

Biophytis H1 EPS $(0.08) Up From $(0.17) YoY

By Benzinga Newsdesk

Today, 10:44 PM

Biophytis (NASDAQ:BPTS) reported quarterly losses of $(0.08) per share. This is a 52.94 percent increase over losses of $(0.17) per share from the same period last year.

BPTS